Who published this market news?

TradingView published this market news item.

Phio Pharmaceuticals adds R. Todd Plott to its Board, joins Governance Committee

Phio Pharmaceuticals appointed R. Todd Plott, M.D. to its Board and named him to the Governance Committee, effective July 20, 2026.Original SEC Filing: Phio Pharmaceuticals Corp. [ PHIO ] - 8-K - Jul. 21, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important i…

Phio Pharmaceuticals appointed R. Todd Plott, M.D. to its Board and named him to the Governance Committee, effective July 20, 2026.

IndividualR. Todd Plott, M.D.

RoleBoard member; Member of Governance Committee

Type of ChangeAppointed

Effective DateJuly 20, 2026

ReasonNot disclosed

Replacement InfoNot disclosed

Background DetailsBoard-certified dermatologist, researcher, inventor, former FDA advisory committee member with 30+ years in dermatologic care and innovation

Board/Committee Role ChangesAppointed to Governance Committee

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.